NORML

AUGUST 26, 2019

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 196

DEA Cultivation Compliance Compliance 196

NORML

MAY 2, 2024

Perhaps most tellingly, our political opponents are also touting its significance, pledging to take whatever steps necessary to derail this proposed policy change. The post Federal Marijuana Rescheduling Announced appeared first on NORML.

Marijuana 323

Marijuana Policy DEA 323

Canna Care Docs

OCTOBER 10, 2024

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. Understanding current drug scheduling for cannabis The DEA classifies drugs, substances, and certain chemicals used to make drugs into five distinct categories or “schedules.”

Patients 111

Patients DEA Research and Development Recreational 111

NORML

JANUARY 15, 2020

Members of the House Energy and Commerce Subcommittee on Health today held a legislative hearing, “ Cannabis Policies for the New Decade ,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. He continued: “The fact of the matter is that legalization and regulation work.

Policy 197

Policy DEA Legislation Data 197

NORML

MARCH 1, 2019

The American Psychological Association (APA) is urging US Attorney General William Barr to review more than two-dozen pending applications for federal marijuana grow licenses. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. .” Also on Wednesday, Rep.

DEA 197

DEA Research and Development Clinical Trials Marijuana 197

NORML

MARCH 26, 2020

The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. ” He added, “Further, the DEA has an incredibly poor track record in this arena – having for years now promised to expedite and streamline this process, but failing to deliver.

Cultivation 244

Cultivation DEA Extraction THC 244

Project CBD

MARCH 7, 2025

According to the study’s THC equivalency scale, the average amount of THC in tested vapes was 2,682 milligrams per cartridge 268% above Californias limit for THC in adult-use cannabis vape products, which is 1,000 milligrams, and also well above the cap for such products under the state medical marijuana program, which is 2,000.

Hemp 230

Hemp Vaping THC Cannabinoids 230

NORML

JANUARY 13, 2020

This Wednesday, January 15th, at 10 am EST, the House Energy and Commerce Subcommittee on Health will hold a legislative hearing entitled “Cannabis Policies for the New Decade.” ” This marks the first time that members of the Energy and Commerce Committee will hear and debate issues specific to marijuana policy reform.

Legislation 186

Legislation Marijuana Policy DEA 186

Cannabis Law Report

SEPTEMBER 1, 2021

Marijuana Moment reports. In its response, the agency argued that marijuana has no currently accepted medical value. Lawyers for the group appealed that decision, asking the court to order DEA to initiate a formal rulemaking process, which would involve expert testimony and public comment. Read the full article at .

DEA 109

DEA Marijuana Policy Cannabis 109

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Less dangerous than marijuana, according to the CSA Schedule, are methamphetamine, cocaine, and hydrocodone. NORML launched the first petition to reschedule marijuana in 1972.

DEA 108

DEA Marijuana History Cannabis 108

NORML

JULY 15, 2020

Of eligible respondents, 72 percent agreed with the statement, “Medical marijuana should be used to reduce the use of opioids for non-cancer pain.” Sixty-three percent of respondents also agreed, “The DEA should reclassify marijuana so that it is no longer a schedule I drug.".

Chronic Pain 246

Chronic Pain Patients DEA Marijuana 246

The Cannigma

JUNE 14, 2021

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We BRC) told The Cannigma this week. Junk’ cannabis ‘ill-suited for clinical trials’. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome. Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. On Monday, the U.S.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

NORML

OCTOBER 21, 2019

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.

DEA 103

DEA Cultivation Clinical Trials Policy 103

NORML

JANUARY 17, 2019

To date, the US National Institute on Drug Abuse designates the University of Mississippi to be the sole provider of marijuana for FDA-approved research. As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.”

Clinical Trials 226

Clinical Trials Legislation DEA Patients 226

WeedAdvisor

AUGUST 28, 2019

A standoff between marijuana researchers and federal drug enforcement may finally have turned in the scientists’ favour. As we reported earlier , marijuana experts were frustrated over the poor quality of cannabis grown at the government’s only legal marijuana facility at the University of Mississippi.

DEA 61

DEA Marijuana History THC 61

CannaMD

MARCH 26, 2024

The recommendation by the FDA and HHS to reclassify marijuana as a Schedule III substance marks a pivotal shift in federal drug policy, acknowledging its medical benefits and potential for lower abuse.

DEA 98

DEA Marijuana Therapy Policy 98

The Blunt Truth

JULY 18, 2022

One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green. million marijuana plants and conducted more than 6,600 marijuana related arrests. billion, with states like Colorado and Oregon bringing in over $2.2

DEA 98

DEA Data Decriminalization Legalization 98

Cannabis Law Report

AUGUST 24, 2020

August 24, 2020 The DEA has not issued a warning or otherwise signaled a change in enforcement policy by issuing the interim final rule. The post Duane Morris Article: DEA Issues Interim Final Rule Concerning Marijuana and Hemp first appeared on Cannabis Law Report. On … Read More.

DEA 59

DEA Hemp Marijuana Policy 59

Medical Marijuana Program Connection

APRIL 30, 2024

Reuters Reports have surfaced indicating that the Biden administration is gearing up to shake up federal drug policy. Drug Enforcement Administration (DEA) is reportedly considering reclassifying marijuana, a move that could mark a significant shift in decades-long restrictions. Read More

Policy 49

Policy DEA Marijuana Legalization 49

CannaMD

JULY 19, 2020

Drug Enforcement Agency (DEA) made far fewer cannabis-related arrests in 2019 than in previous years. Let’s take a closer look at what DEA data reveals. But despite all the DEA’s seizing and destroying, it’s clear that the average U.S. That’s what DEA data indicates, at least — especially when looked at closely.

DEA 59

DEA Marijuana Data Decriminalization 59

SpeedWeed

MAY 11, 2021

million marijuana plants in 2020, a figure that is up nearly 20% over 2019. The annual DEA report also shows that federal law enforcement officers made nearly 5,000 cannabis-related arrests in 2020, a year wracked by the social and economic fallout of the Covid-19 pandemic. Data recently released by the U.S.

DEA 52

DEA Marijuana Data Programs 52

FloridaMarijuana.net

JULY 8, 2018

Medical marijuana can contribute to a patient’s overall health. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the debilitating symptoms of PTSD. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs).

Strains 190

Strains Indica Hybrid Research and Development 190

Veriheal

JANUARY 16, 2024

This occasion marks the first time that a federal agency has recommended rescheduling cannabis, and this could be the push the Drug Enforcement Administration (DEA) needs to finally make it happen. What Would Rescheduling Mean For Marijuana?

DEA 122

DEA Medicine Cannabis Legalization 122

The Blunt Truth

OCTOBER 15, 2019

Medical Marijuana, Inc., We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1%

THC 87

THC CBD DEA Policy 87

The Blunt Truth

APRIL 2, 2020

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. We’ve got lots to report on how the pandemic is affecting marijuana, but let’s start with other news first. DEA GUIDANCE. SOUTH DAKOTA. ” Ouch. But that’s not all. CORONAVIRUS LAWS.

DEA 101

DEA Hemp Packaging Recreational 101

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis. DEA finally relents.

DEA 52

DEA Research and Development Data Cannabis 52

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference.

DEA 45

DEA Law Policy Safety 45

United Patients Group

JANUARY 15, 2023

CBD is derived from hemp or marijuana plants, both species of Cannabis Sativa. CBD does not give the user the feeling of being “high,” which is commonly associated with marijuana containing higher amounts of THC, over 0.3 %. However, the DEA and FDA still consider CBD a drug regulated under the Schedule I classification.

THC 130

THC CBD DEA Cannabinoids 130

SpeedWeed

MARCH 4, 2021

Seizures of illicit marijuana at the U.S. In the 2020 National Drug Threat Assessment , which was released by the DEA on Wednesday, the agency notes that despite its continued illegality under federal law, marijuana “is the most commonly used illicit drug in the United States.”. The DEA explains that in 2019, U.S.

DEA 52

DEA Supply Chain Advocacy Recreational 52

SpeedWeed

MARCH 10, 2021

Well, the DEA just released its 2020 National Drug Threat Assessment, and the report is full of stats on the United States’ most popular illegal addictions, new trends in intoxicants, and foreign trade — a.k.a. The US sourced 92 percent of its heroin from Mexico in 2019, according to product analyzed by a DEA tracing program.

DEA 52

DEA Hemp Cannabinoids Legalization 52

MJ Business Attorneys

MARCH 1, 2018

CannaTech showcases the biggest industry thought leaders, known for their significant and groundbreaking contributions to the global cannabis market in fields such as science, finance, government policy and tech. policy towards marijuana. ” and he will be discussing the following: A brief history of the U.S.

DEA 100

DEA Policy History Compliance 100

Canna Law Blog

MARCH 30, 2019

As we previously discussed , thus far, the FDA has only adopted informal, non-binding guidelines as its primary method of policy making for CBD as they afford the agency more flexibility. I think the prevailing view is that the plain language of the statute [the Farm Bill] intended for that, but I’m not sure that DEA has done that yet.

Food 95

Food CBD DEA Legalization 95

Medical Marijuana Program Connection

APRIL 25, 2024

… concerning consequences of marijuana prohibition is to deschedule marijuana altogether,” the … widening gulf between restrictive federal marijuana laws and increasingly loose … years of failed, racially discriminatory marijuana policy,” they said. Read More

DEA 49

DEA Marijuana Policy Law 49

MJ Business Attorneys

MAY 29, 2018

Murphy had a number of marijuana law reform scholars as amici (impartial, voluntary advisors) in the case, and the reason is because the holding in Murphy directly impacts marijuana legalization. What this does not mean is that the federal government may not prohibit marijuana.

Policy 100

Policy State Laws DEA Legislation 100

Cannabis Law Report

JUNE 16, 2022

million cultivated marijuana plants and made more than 6,600 marijuana-related arrests in 2021, according to annual data compiled by the US Drug Enforcement Administration. . Law enforcement also reported making 6,606 marijuana-related arrests, a 25 percent increase over the prior year’s totals (when agents reported 4,992 arrests).

DEA 52

DEA Marijuana Data Programs 52

Veriheal

JULY 29, 2021

Office of National Drug Control Policy defined that the medal “seemed to directly undercut our messages to young people that drug use undermines a child’s opportunities for success.” Fast forward to 2019 and the DEA unveiled eagerly anticipated plans for cannabis research. Soon after Rebagliati’s case, a paper released by the U.S.

DEA 98

DEA Cannabis Cannabinoids Sativa 98